These findings reveal that the IGF2BP3-related metabolic score can serve as a predictor of HCC prognosis, and grouping based on metabolic scores could be an effective strategy for predicting the survival of individuals with HCC. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.